Optometrists in New Palestine, IN Accepting Medicare

2 Optometrists found. Showing 1 - 2

Best In Sight Family Eye Care P C Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4037 S Arbor Lane, Ste B, New Palestine, IN 46163 Phone: 317-861-4100    Fax: 317-861-7280

Dr. Randall A. Faunce, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 6829 W Rockwood Ln, New Palestine, IN 46163 Phone: 317-861-0755

News Archive

Delaying gratification at 4 years of age may affect weight later in life

As adults, we know that self-control and delaying gratification are important for making healthful eating choices, portion control, and maintaining a healthy weight. However, exhibiting these skills at a young age actually may affect weight later in life. A new study scheduled for publication in The Journal of Pediatrics finds that delaying gratification longer at 4 years of age is associated with having a lower body mass index (BMI) 30 years later.

Myriant closes $60M strategic equity investment from PTT Chemical

Myriant Technologies, Inc., a privately-held, biotech developer and manufacturer of renewable bio-based chemicals, announced today the closing of a $60 million strategic equity investment from PTT Chemical Group, Thailand's largest petrochemical producer.

Patients with community-acquired pneumonia have high rates of long-term morbidity and mortality

Having had community-acquired pneumonia (CAP) greatly increases the risk of long-term morbidity and mortality compared to the general population who have never had CAP, according to a new study from researchers in Canada, the longest and largest outcomes study of patients with CAP reported to date.

New anti-cancer drug may protect normal cells against radiation

Although radiation treatments have become much more refined in recent years, it remains a challenge to both sufficiently dose the tumor while sparing the surrounding tissue.

ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating form of human EPO

Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.

Read more Medical News

› Verified 1 days ago